Characteristics | Summary |
Lung adenocarcinoma patients | N = 503 |
Age | 66.0±9.5 years |
Gender | 45.6% Male; 54.4% Female |
Stage | |
Stage Ⅰ | 268 (53.3%) |
Stage Ⅱ | 121 (24.1%) |
Stage Ⅲ | 83 (16.5%) |
Stage Ⅳ | 26 (5.2%) |
Citation: Gaozhong Sun, Tongwei Zhao. Lung adenocarcinoma pathology stages related gene identification[J]. Mathematical Biosciences and Engineering, 2020, 17(1): 737-746. doi: 10.3934/mbe.2020038
[1] | Kunpeng Li, Zepeng Wang, Yu Zhou, Sihai Li . Lung adenocarcinoma identification based on hybrid feature selections and attentional convolutional neural networks. Mathematical Biosciences and Engineering, 2024, 21(2): 2991-3015. doi: 10.3934/mbe.2024133 |
[2] | Yanping Xie, Zhaohui Dong, Junhua Du, Xiaoliang Zang, Huihui Guo, Min Liu, Shengwen Shao . The relationship between mouse lung adenocarcinoma at different stages and the expression level of exosomes in serum. Mathematical Biosciences and Engineering, 2020, 17(2): 1548-1557. doi: 10.3934/mbe.2020080 |
[3] | Yong Ding, Jian-Hong Liu . The signature lncRNAs associated with the lung adenocarcinoma patients prognosis. Mathematical Biosciences and Engineering, 2020, 17(2): 1593-1603. doi: 10.3934/mbe.2020083 |
[4] | Pingping Song, Jing Chen, Xu Zhang, Xiaofeng Yin . Construction of competitive endogenous RNA network related to circular RNA and prognostic nomogram model in lung adenocarcinoma. Mathematical Biosciences and Engineering, 2021, 18(6): 9806-9821. doi: 10.3934/mbe.2021481 |
[5] | Xinwang Yan, Xiaowen Zhao, Qing Yan, Ye Wang, Chunling Zhang . Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network. Mathematical Biosciences and Engineering, 2021, 18(5): 6608-6619. doi: 10.3934/mbe.2021327 |
[6] | Xiao Chu, Weiqing Wang, Zhaoyun Sun, Feichao Bao, Liang Feng . An N6-methyladenosine and target genes-based study on subtypes and prognosis of lung adenocarcinoma. Mathematical Biosciences and Engineering, 2022, 19(1): 253-270. doi: 10.3934/mbe.2022013 |
[7] | Bijiong Wang, Yaodong Tang, Biyun Yu, Di Gui, Hui Xu . Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: A systematic review and meta-analysis. Mathematical Biosciences and Engineering, 2019, 16(6): 6805-6821. doi: 10.3934/mbe.2019340 |
[8] | Ji-Ming Wu, Wang-Ren Qiu, Zi Liu, Zhao-Chun Xu, Shou-Hua Zhang . Integrative approach for classifying male tumors based on DNA methylation 450K data. Mathematical Biosciences and Engineering, 2023, 20(11): 19133-19151. doi: 10.3934/mbe.2023845 |
[9] | Siqi Hu, Fang Wang, Junjun Yang, Xingxiang Xu . Elevated ADAR expression is significantly linked to shorter overall survival and immune infiltration in patients with lung adenocarcinoma. Mathematical Biosciences and Engineering, 2023, 20(10): 18063-18082. doi: 10.3934/mbe.2023802 |
[10] | Jian Huang, Zheng-Fu Xie . Identification of SSBP1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Mathematical Biosciences and Engineering, 2022, 19(3): 3022-3035. doi: 10.3934/mbe.2022139 |
Lung cancer is a deadly disease with a 5-year survival rate of less than 15% and has two main subtypes which are known as non-small-cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC) [1,2]. Lung adenocarcinoma is the main subtype of NSCLC. Previous studies have shown that lung adenocarcinoma patients have a shorter survival time than patients with another subtype of NSCLC [3].
Cancer staging is the process of determining the extent to which a cancer has developed by growing and spreading and provides a standardized framework to define the spread of a tumor [4]. Correct staging is critical as the basis of treatment (particularly the need for pre-operative therapy and/or for adjuvant treatment, the extent of surgery). Thus, incorrect staging would lead to improper treatment. Previous studies have suggested that lung cancer stages are associated with the prognosis of patients [5,6]. Patients in the early stages of lung cancer tend to live longer than those in later stages. Thus, it is important to identify genes associated with cancer staging which would be helpful in understanding the pathological mechanism and designing targeted therapeutic drugs.
Many gene selection methods are based on univariate rankings of gene relevance and arbitrary thresholds to select relevant genes. Most of these approaches can only be applied to two-class problems [7]. So, these methods do not suit to identify genes associated with pathologic stages of lung adenocarcinoma. Some methods can only distinguish genes with a linear correlation between expression levels and the outcome. However, the relationship between gene expression and outcome may be non-linear. Random forest is a machine learning method suited for classification in gene expression data [7,8]. It can be used when the number of observations is much smaller than the number of variables even when many of predictive variables are noise [7] and can be applied to problems containing more than two classes. And the returned variable importance is helpful in selecting the relevant genes which may be useful to predict the outcome.
In this study, we used the significance threshold of 2.52 × 10-5 (0.05 19879, Bonferroni correction) in random forest to identify genes that may lead to pathological staging of lung adenocarcinoma., and the molecular mechanism related to pathological staging was further explored by PPI analysis and GSEA enrichment analysis.
The gene expression data of 572 patients and the corresponding clinical follow-up information were downloaded from the Cancer Genome Atlas (TCGA) databases. After removing those without pathologic stages information, totally 503 patients were included in this analysis. The RNA sequencing data of all patients' tumor tissues were standardized and then normalized within and among the left samples. We defined that a gene was abundantly expressed when its expression level was above 0 and appeared in at least 50% of the total samples.
Random forest is a machine learning approach used for classification and regression developed by Leo Breiman [9]. Based on a bootstrap sample of the data, each of the classification trees was split using a random subset of the candidate variables. To select the variables identified by random forest method, we used a computationally fast variable importance test method by conducting with standard procedure in R packages vita [10]. The previous study suggests that this method is a powerful approach suitable for high-dimensional data (e.g. gene expression data). Especially, when there are no predictor variables associated with the trait under a null model, the method vita is the most robust [10,11]. Unlike other permutation-based methods [12], vita approach only uses the existed data to estimate the null distribution of the variable importance [10]. In summary, the vita approach divides the whole data into two equally sized subsets, and two random forests are trained by using either of the two subsets. The variable importance is then calculated based on the other subset [10]. The variable importance showed the importance of each gene expression for classification into 4 stages. Finally, p values are calculated based on the distribution of variable importance [10].
To evaluate the interaction between identified gens, we extracted a small PPI network from the whole PPI network which was downloaded from cisPath database with the following link http://www.isb.pku.edu.cn/cispath/ [13]. The cisPath database contains PPI data from UniProt [14], PINA [15], iRefIndex [16] and STRING database [17]. The method SubNet was used to extract the small PPI network [18]. The subnetwork was then visualized the networks by Cytoscape [19].
We performed Gene Set Enrichment Analysis (GSEA) with the software provided by the Massachusetts Institute of Technology [PMID:16199517]. GSEA is a computational method that determines whether a priori defined set of genes shows statistically significant, concordant differences between two biological states. In our study, the identified genes were analyzed by GSEA single gene functional enrichment analysis, and the enrichment results were shown by bubble diagram.
Totally 503 patients were included in this analysis, after removing those without pathologic stages information. Details of clinical information were shown in Table 1. After removing those genes with low expression, totally 19,879 genes were contained in the analysis. So, the significant threshold of variable importance test was set to 2.52 × 10-5 (0.05/19879, Bonferroni correction). Based on this criterion, we identified 12 genes significantly associated with pathologic stages of lung adenocarcinoma. These genes with p value from the variable importance test were summarized in Table 2.
Characteristics | Summary |
Lung adenocarcinoma patients | N = 503 |
Age | 66.0±9.5 years |
Gender | 45.6% Male; 54.4% Female |
Stage | |
Stage Ⅰ | 268 (53.3%) |
Stage Ⅱ | 121 (24.1%) |
Stage Ⅲ | 83 (16.5%) |
Stage Ⅳ | 26 (5.2%) |
Gene names | Variable importance | p value |
ACSS1 | 2.12 × 10-4 | 2.16 × 10-16 |
LOC101928882 | 1.87 × 10-4 | 2.19 × 10-16 |
ZNF546 | 1.42 × 10-4 | 2.21 × 10-16 |
KCNC1 | 1.39× 10-4 | 2.21× 10-16 |
NSG1 | 1.38 × 10-4 | 2.21 × 10-16 |
PITX2 | 1.25 × 10-4 | 2.22 × 10-16 |
CENPH | 1.25 × 10-4 | 2.22 × 10-16 |
BCAT2 | 1.21 × 10-4 | 2.23× 10-16 |
MEI1 | 1.20 × 10-4 | 2.23 × 10-16 |
SRSF5 | 1.20 × 10-4 | 2.23 × 10-16 |
ZNF432 | 1.20 × 10-4 | 2.23 × 10-16 |
CNTN3 | 1.18 × 10-4 | 2.23 × 10-16 |
With the 12 genes, we constructed a pathologic stage classifier which could accurately predict the multi-stages of each patient with the area under the curve (AUC) of 0.899 using the random forest method. The receiver operating characteristic (ROC) curve for pathologic stage I was shown in Figure 1.
Then, we found that ACSS1 (p < 0.001), CNTN3 (p = 0.009), BCAT2 (p = 0.032), MEI1 (p = 0.03), NSG1 (p = 0.042), LOC101928882 (p < 0.001), ZNF546 (p = 0.037) and CENPH (p < 0.001) were associated with prognosis by univariate regression analysis of 12 genes (Figure 2). Also, we found that ACSS1, CENPH, CNTN3, KCNC1, MEI1, NSG1, SRSF5, ZNF432 and ZNF546 were significantly differentially expressed in different pathological stages (Figure 3). The gene expression of MEI1 and ACSS1 decreased with the occurrence and development of lung adenocarcinoma, while the gene expression of PITX2 and CENPH increased with the occurrence and development of lung adenocarcinoma.
We used SubNet to extract the small network from the whole PPI network. The result was displayed graphically in Figure 4. The genes obtained from PPI network were intersected with 12 genes screened by Random forest, and the four genes in the intersection were analyzed by GSEA single gene functional enrichment analysis, and the enrichment results were shown by bubble diagram as shown in Figure 5. Single gene functional enrichment analysis showed that CENPH and SRSF5 were mainly enriched on P53 signaling pathway and cell cycle signaling pathway, PITX2 was mainly enriched on toll like receptor signaling pathway and JAK/STAT signaling pathway, and NSG1 was mainly enriched on JAK/STAT signaling pathway, DNA replication and cell cycle signaling pathway.
In this study, we identified 12 genes significantly associated with pathologic stages of lung adenocarcinoma based on the random forest method. Many of them were found to play an import role in the tumor process, such as growth and metastasis.
Some of these genes were found to be differently expressed in tumor tissue compared with normal tissue. KCNC1 was found to be highly expressed in lung tumor tissue compared with normal tissues [20]. We found that the expression of KCNC1 was different in different cancer stages. NSG1 was identified as a biomarker for lung cancer early diagnosis [21]. We compared the expression of NSG1 in early stage (stage Ⅰ) and later stages and found that the expression of NSG1 was significantly higher in early stage than later stages (p value = 0.00023). This also suggested that NSG1 was associated with different cancer stages. On the other hand, single gene enrichment analysis of NSG1 was carried out by GSEA, and it was found that NSG1 was mainly enriched on JAK/STAT signaling pathway, DNA replication and cell cycle signaling pathway. It suggested that NSG1 may regulate the occurrence and development of lung adenocarcinoma through the above signaling pathways. In both head and neck region of squamous cell carcinoma and lung cancer patients, the methylation status of PITX2 was significantly associated with the survival status [22,23,24]. Since lung cancer stages are associated with the prognosis of patients [5,6], it is consistent with our results. CENPH protein, together with CENPA protein and CENPC protein, is a fundamental component of the active kinetochore complex [25,26]. The expression of CENPH was much higher in NSCLC cell lines and tumor tissues. Patients with a higher expression level of CENPH tended to have worse overall survival compared with patients with lower expression levels of CENPH [27], and our study found that the gene expression level of CENPH increased with the occurrence and development of lung cancer. The expression of SRSF5 was found to be highly expressed in tumor tissue. Knockdown of SRSF5 gene expression significantly reduced NSCLC cell proliferation [28]. In addition, using GSEA enrichment analysis, we found that SRSF5 may regulate the proliferation of lung adenocarcinoma cells through p53 signaling pathway and cell cycle signaling pathway.
Three of these genes were found to play important roles in the tumor process. With the help of acetate, glutamine supplementation is able to prevent loss of cell viability and support cell survival [29]. ACSS1, one type of acetyl-CoA synthetases, converted acetate to acetyl-CoA [30]. ACSS1 incorporates fatty acids into membranes to store energy and paly roles in metabolism [31]. However, short chain fatty acids cannot prevent the loss of cell viability from glucose deprivation [29]. In vivo studies also suggested that ACSS1 was a key factor in tumor growth in mice [29]. Our study suggested that ACSS1 was associated with different cancer stages, and the gene expression level of ACSS1 decreased gradually with the occurrence and development of lung adenocarcinoma. Depletion of BCAT2 was found to be able to impair the ability of lung tumor cell line to form a subcutaneous and orthotopic tumor in recipient mice [32].
In conclusion, we identified 12 genes associated with pathologic stages of lung adenocarcinoma by using random forest approach. Most of these genes were found to be important for cell proliferation or survival by previous studies. The left genes were warranted to find their significance. These genes will be helpful in understanding molecular changes underlying the pathologic stages.
The authors declare no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
[1] | D. S. Ettinger, W. Akerley, H. Borghaei, et al., Non-small cell lung cancer, version 2, 2013, J. Natl. Compr. Canc. Netw., 11 (2013), 645-653, quiz 653. |
[2] | R. Siegel, D. Naishadham and A. Jemal, Cancer statistics, 2013, CA Cancer J. Clin., 63 (2013), 11-30. |
[3] | D. E. Williams, P. C. Pairolero, C. S. Davis, et al., Survival of patients surgically treated for stage I lung cancer, J. Thorac. Cardiovasc. Surg., 82 (1981), 70-76. |
[4] | G. A. Woodard, K. D. Jones and D. M. Jablons, Lung Cancer Staging and Prognosis, Cancer Treat. Res., 170 (2016), 47-75. |
[5] | K. H. Yu, C. Zhang, G. J. Berry, et al., Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features, Nat. Commun., 7 (2016), 12474. |
[6] | F. C. Detterbeck, D. J. Boffa and L. T. Tanoue, The new lung cancer staging system, Chest, 136 (2009), 260-271. |
[7] | R. Diaz-Uriarte and S. Alvarez de Andres, Gene selection and classification of microarray data using random forest, BMC Bioinform., 7 (2006), 3. |
[8] | V. A. Huynh-Thu, A. Irrthum, L. Wehenkel, et al., Inferring regulatory networks from expression data using tree-based methods, PLoS One, 5 (2010). |
[9] | L. Breiman, Random Forests, Mach. Learn., 45 (2001). |
[10] | S. Janitza, E. Celik and A. L. Boulesteix, A computationally fast variable importance test for random forests for high-dimensional data, Adv. Data Anal. Classific., (2016). |
[11] | F. Degenhardt, S. Seifert and S. Szymczak, Evaluation of variable selection methods for random forests and omics data sets, Brief Bioinform., (2017). |
[12] | A. Altmann, L. Tolosi, O. Sander, et al., Permutation importance: a corrected feature importance measure. Bioinformatics, 26 (2010), 1340-1347. |
[13] | L. Wang, L. Yang, Z. Peng, et al., cisPath: an R/Bioconductor package for cloud users for visualization and management of functional protein interaction networks, BMC Syst. Biol., 9 (2015), S1. |
[14] | A. Noto, S. Raffa, C. De Vitis, et al., Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells, Cell Death Dis., 4 (2013), e947. |
[15] | M. J. Cowley, K. S. Pinese, N. Kassahn, et al., PINA v2.0: Mining interactome modules, Nucleic Acids Res., 1 (2012), 40. |
[16] | S. Razick, I. M. Magklaras and I. M. Donaldson, iRefIndex: A consolidated protein interaction database with provenance, BMC Bioinform., 9 (2008), 405. |
[17] | A. Franceschini, S. Szklarczyk, M. Frankild, et al., STRING v9.1: Protein-protein interaction networks, with increased coverage and integration, Nucleic Acids Res., 11 (2013), 41. |
[18] | C. Lemetre, Q. Zhang and Z. D. Zhang, SubNet: A Java application for subnetwork extraction, Bioinformatics, 29 (2013), 2509-2511. |
[19] | P. Shannon, O. Markiel, N. S. Ozier, et al., Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res., 13 (2003), 2498-2504. |
[20] | Y. J. Kwon, S. J. Lee, J. S. Koh, et al., Genome-wide analysis of DNA methylation and the gene expression change in lung cancer, J. Thora. Onco., 7 (2012), 20-33. |
[21] | J. Pan, G. Song, D. Chen, et al., Identification of serological biomarkers for early diagnosis of lung cancer using a protein array-based approach, Mol. Cell. Proteom., (2017). |
[22] | E. E. Holmes, M. Jung, S. Meller, et al., Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine, PLoS One, 9 (2014), e93933. |
[23] | V. Sailer, E. E. Holmes, H. Gevensleben, et al., PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma, Clin. Epigenet., 9 (2017), 12. |
[24] | V. Sailer, E. E. Holmes, H. Gevensleben, et al., PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Oncotarget, 7 (2016), 75827-75838. |
[25] | T. Fukagawa, A. Mikami, V. Nishihashi, et al., CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells, EMBO J., 20 (2001), 4603-4617. |
[26] | N. Sugata, W. C. Li, T. J. Earnshaw, et al., Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere--kinetochore complexes, Hum. Mol. Genet., 9 (2000), 2919-2926. |
[27] | W. T. Liao, X. Wang, L. H. Xu, et al., Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival, Cancer, 115 (2009), 1507-1517. |
[28] | H. R. Kim, G. O. Lee, K. H. Choi, et al., SRSF5: A novel marker for small-cell lung cancer and pleural metastatic cancer, Lung Cancer, 99 (2016), 57-65. |
[29] | A. J. Lakhter, J. Hamilton, R. L. Konger, et al., Glucose-independent acetate metabolism promotes melanoma cell survival and tumor growth, J. Biol. Chem., 291 (2016), 21869-21879. |
[30] | L. K. Boroughs and R. J. DeBerardinis, Metabolic pathways promoting cancer cell survival and growth, Nat. Cell. Biol., 17 (2015), 351-359. |
[31] |
P. A. Watkins, D. Maiguel, Z. Jia, et al., Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome, J. Lipid. Res., 48 (2007), 2736-2750. doi: 10.1194/jlr.M700378-JLR200
![]() |
[32] | E. M. Kerr and C. P. Martins, Metabolic rewiring in mutant Kras lung cancer, FEBS J., 285 (2018), 28-41. |
1. | Weiyang Cai, Wei Ni, Yin Jin, Yanyan Li, TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling, 2021, 30, 18758592, 237, 10.3233/CBM-200039 | |
2. | Peng Cao, Fan Li, Yajie Xiao, Shan Hu, Kangle Kong, Peng Han, Jiaqi Yue, Yu Deng, Zhikun Zhao, Dongfang Wu, Lu Zhang, Bo Zhao, Yuanwei Zhang, Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis, 2022, 2022, 1875-8630, 1, 10.1155/2022/5118444 | |
3. | Arash Seifi, Nahid Shafiee, Maryam Moradi, Pulmonary adenocarcinoma mimicking miliary tuberculosis in a 20‐year‐old man: A clinical case report, 2023, 11, 2050-0904, 10.1002/ccr3.7028 | |
4. | Kun Lan, Gloria Li, Yang Jie, Rui Tang, Liansheng Liu, Simon Fong, Convolutional neural network with group theory and random selection particle swarm optimizer for enhancing cancer image classification, 2021, 18, 1551-0018, 5573, 10.3934/mbe.2021281 | |
5. | Xue Lian, Dakui Cao, Xun Hu, Weiqiang Mo, Xiujuan Yao, Juanfen Mo, Haiqin Wang, Circular RNAs Hsa_circ_101555 and Hsa_circ_008068 as Diagnostic Biomarkers for Early-Stage Lung Adenocarcinoma, 2022, Volume 15, 1178-7074, 5579, 10.2147/IJGM.S367999 | |
6. | Hongfei Guo, Tao Li, Chunlei Peng, Qinghua Mao, Biao Shen, Minxin Shi, Haimin Lu, Ting Xiao, Aimin Yang, Yupeng Liu, Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness via regulating the miR-587/bone morphogenetic protein 3 axis in lung adenocarcinoma, 2022, 41, 0960-3271, 096032712211389, 10.1177/09603271221138971 | |
7. | Yang Xue, Mingqiang Diao, Jing Lyu, Kang Li, Long He, Junfeng Chen, Xiangguo Li, Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung Adenocarcinoma, 2021, 1084-9785, 10.1089/cbr.2021.0168 | |
8. | Tao Zuo, Ping Jiang, Jun Fu, Yongjian Zhang, LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis, 2023, Volume 19, 1178-203X, 1, 10.2147/TCRM.S374162 | |
9. | Fan Yang, Yan Zhao, Xiaohan Huang, Jin Zhang, Ting Zhang, Yaying Sun, A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma, 2022, 2022, 1469-5073, 1, 10.1155/2022/3483498 | |
10. | Xingjun Liu, Yi Wang, Guixing Zhou, Jinbo Zhou, Zhongmin Tian, Jie Xu, circGRAMD1B contributes to migration, invasion and epithelial-mesenchymal transition of lung adenocarcinoma cells via modulating the expression of SOX4, 2023, 23, 1438-793X, 10.1007/s10142-023-00972-x | |
11. | Manish Purohit, Gaurav Gupta, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Sami I. Alzarea, Imran Kazmi, Waleed Hassan Almalki, Monica Gulati, Indu Pal Kaur, Sachin Kumar Singh, Kamal Dua, Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease, 2023, 371, 00092797, 110334, 10.1016/j.cbi.2023.110334 | |
12. | Jinyuan Liu, Chunfeng Pan, Rongxin Lu, Shijiang Zhang, Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells, 2022, 13, 2165-5979, 7868, 10.1080/21655979.2022.2050968 | |
13. | Jin Ouyang, Zhijian Hu, Jianlin Tong, Yong Yang, Juan Wang, Xi Chen, Ting Luo, Shiqun Yu, Xin Wang, Shaoxin Huang, Construction and evaluation of a nomogram for predicting survival in patients with lung cancer, 2022, 14, 1945-4589, 2775, 10.18632/aging.203974 | |
14. | Pengchen Liang, Jin Li, Jianguo Chen, Junyan Lu, Zezhou Hao, Junfeng Shi, Qing Chang, Zeng Zeng, Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs, 2022, 12, 2045-2322, 10.1038/s41598-022-11052-8 | |
15. | Zhaoshui Li, Zaiqi Ma, Hong Xue, Ruxin Shen, Kun Qin, Yu Zhang, Xin Zheng, Guodong Zhang, Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma, 2022, 13, 1664-8021, 10.3389/fgene.2022.917150 | |
16. | Xiaofan Xia, Jinxiu Fan, Zhongjie Fan, Hsa_circ_0129047 sponges miR-665 to attenuate lung adenocarcinoma progression by upregulating protein tyrosine phosphatase receptor type B, 2023, 27, 1226-4512, 131, 10.4196/kjpp.2023.27.2.131 | |
17. | Yulin Wang, Jiaqi Li, Xue Zhang, Man Liu, Longtao Ji, Ting Yang, Kaijuan Wang, Chunhua Song, Peng Wang, Hua Ye, Jianxiang Shi, Liping Dai, Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer, 2023, 246, 15216616, 109206, 10.1016/j.clim.2022.109206 | |
18. | Dongjie Sun, Haiying Zhang, Chi Zhang, Lina Wang, An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis, 2022, 10, 2296-4185, 10.3389/fbioe.2022.993820 | |
19. | Kunming Zhang, Xiwen Sun, Weikai Sun, Meng Wang, Fushi Han, Exosomal microRNA-506 inhibits biological activity of lung adenocarcinoma cells and increases sensitivity to cisplatin-based hyperthermia, 2022, 100, 08986568, 110469, 10.1016/j.cellsig.2022.110469 | |
20. | Longhua Feng, Pengjiang Cheng, Zhengyun Feng, Xiaoyu Zhang, Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma, 2022, 20, 1477-7819, 10.1186/s12957-021-02477-y | |
21. | Lina Ma, Lu Zhang, Lin Li, Li Zhao, The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma, 2023, 18, 2391-5463, 10.1515/med-2023-0686 | |
22. | Erica Vettori, Alberto Borella, Fulvia Costantinides, Roberto Rizzo, Michele Maglione, Mandibular metastasis of pulmonary adenocarcinoma: How unexpected could it be?, 2024, 41, 0734-0664, 283, 10.1111/ger.12707 | |
23. | Fahim Anwar Rizwi, Md. Abubakar, Eswara Rao Puppala, Ahsas Goyal, Ch. Veera Bhadrawamy, V. G. M. Naidu, S. Roshan, B. Tazneem, Waleed Hassan Almalki, Vetriselvan Subramaniyan, Sushama Rawat, Gaurav Gupta, Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer , 2023, 42, 0731-8898, 15, 10.1615/JEnvironPatholToxicolOncol.2023045403 | |
24. | Semra Melis Soyer, Pemra Ozbek, Ceyda Kasavi, Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline, 2024, 28, 1557-8100, 408, 10.1089/omi.2024.0121 | |
25. | Liusheng Wu, Qi Liu, Xin Ruan, Xinyu Luan, Yanfeng Zhong, Jixian Liu, Jun Yan, Xiaoqiang Li, Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD), 2023, 11, 2227-9059, 1861, 10.3390/biomedicines11071861 | |
26. | Jiangzhou Zhang, Shuheng Bai, Yanli Yan, Haojing Kang, Guangzu Li, Zhaode Feng, Wen Ma, Xuan Wang, Juan Ren, Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma, 2023, 23, 1471-2466, 10.1186/s12890-023-02545-x | |
27. | Mingshu Tu, Xiaoqing Yin, Wanzhen Zhuang, Xiaoqing Lin, Yu Xia, Zhixin Huang, Yue Zheng, Yi Huang, NSG1 promotes glycolytic metabolism to enhance Esophageal squamous cell carcinoma EMT process by upregulating TGF-β, 2023, 9, 2058-7716, 10.1038/s41420-023-01694-6 | |
28. | Miao He, Yuxue Zhi, Chao Li, Changming Zhao, Guangquan Yang, Jing Lv, Hong You, Hai Huang, Xiaoyu Cao, Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma, 2024, 16, 1945-4589, 11318, 10.18632/aging.206004 | |
29. | Hui Yu, Xianrong Xu, Lirong Zhu, Shengjie Chen, Jincheng He, MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2, 2024, 28, 1582-1838, 10.1111/jcmm.18216 | |
30. | Hao Fan, Mingjie Dong, Chaomin Ren, Pengfei Shao, Yu Gao, Yushan Wang, Yi Feng, A novel signature integrated endoplasmic reticulum stress and apoptosis related genes to predict prognosis for breast cancer, 2024, 10, 24058440, e28279, 10.1016/j.heliyon.2024.e28279 | |
31. | Haoyun Zhang, Ying Li, Ran Wang, Xindan Hu, Zai Wang, Neuron-Specific Gene Family Member 1 is a Potential New Therapeutic Target Associated with Immune Cell Infiltration for Breast Cancer, 2024, Volume 16, 1179-1314, 769, 10.2147/BCTT.S483757 | |
32. | Wenhui Xu, Jinghong Ye, Zhendong Cao, Yupei Zhao, Yimin Zhu, Lei Li, Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy, 2024, 10, 24058440, e32357, 10.1016/j.heliyon.2024.e32357 | |
33. | Qingqing Ma, Dengming Ma, Mu Lin, Yadong Gong, Xiaojing Han, Yunhua Chen, Zhu Tang, Mubo Liu, Junyan Liu, [Retracted] Analysis of Multigene Mutations in Lung Adenocarcinoma in Zunyi, 2021, 2021, 2314-6133, 10.1155/2021/9939065 | |
34. | Lingxue Tang, Tong Wang, A fatty acid metabolism-related genes model for predicting the prognosis and immunotherapy effect of lung adenocarcinoma, 2024, 41, 1574-0153, 10.1177/18758592241296285 |
Characteristics | Summary |
Lung adenocarcinoma patients | N = 503 |
Age | 66.0±9.5 years |
Gender | 45.6% Male; 54.4% Female |
Stage | |
Stage Ⅰ | 268 (53.3%) |
Stage Ⅱ | 121 (24.1%) |
Stage Ⅲ | 83 (16.5%) |
Stage Ⅳ | 26 (5.2%) |
Gene names | Variable importance | p value |
ACSS1 | 2.12 × 10-4 | 2.16 × 10-16 |
LOC101928882 | 1.87 × 10-4 | 2.19 × 10-16 |
ZNF546 | 1.42 × 10-4 | 2.21 × 10-16 |
KCNC1 | 1.39× 10-4 | 2.21× 10-16 |
NSG1 | 1.38 × 10-4 | 2.21 × 10-16 |
PITX2 | 1.25 × 10-4 | 2.22 × 10-16 |
CENPH | 1.25 × 10-4 | 2.22 × 10-16 |
BCAT2 | 1.21 × 10-4 | 2.23× 10-16 |
MEI1 | 1.20 × 10-4 | 2.23 × 10-16 |
SRSF5 | 1.20 × 10-4 | 2.23 × 10-16 |
ZNF432 | 1.20 × 10-4 | 2.23 × 10-16 |
CNTN3 | 1.18 × 10-4 | 2.23 × 10-16 |
Characteristics | Summary |
Lung adenocarcinoma patients | N = 503 |
Age | 66.0±9.5 years |
Gender | 45.6% Male; 54.4% Female |
Stage | |
Stage Ⅰ | 268 (53.3%) |
Stage Ⅱ | 121 (24.1%) |
Stage Ⅲ | 83 (16.5%) |
Stage Ⅳ | 26 (5.2%) |
Gene names | Variable importance | p value |
ACSS1 | 2.12 × 10-4 | 2.16 × 10-16 |
LOC101928882 | 1.87 × 10-4 | 2.19 × 10-16 |
ZNF546 | 1.42 × 10-4 | 2.21 × 10-16 |
KCNC1 | 1.39× 10-4 | 2.21× 10-16 |
NSG1 | 1.38 × 10-4 | 2.21 × 10-16 |
PITX2 | 1.25 × 10-4 | 2.22 × 10-16 |
CENPH | 1.25 × 10-4 | 2.22 × 10-16 |
BCAT2 | 1.21 × 10-4 | 2.23× 10-16 |
MEI1 | 1.20 × 10-4 | 2.23 × 10-16 |
SRSF5 | 1.20 × 10-4 | 2.23 × 10-16 |
ZNF432 | 1.20 × 10-4 | 2.23 × 10-16 |
CNTN3 | 1.18 × 10-4 | 2.23 × 10-16 |